Microbial environment, immunity and human health

Sophisticated analytical tools for elucidating genome structure and life of bacteria yielded a new paradigm on our relation to the microbial environment. Formerly, bacteria were seen as jeopardising invaders, and studies on bacterial pathogenesis were the basis for great medical progress in the rest...

Повний опис

Збережено в:
Бібліографічні деталі
Опубліковано в: :Екологічна безпека та природокористування
Дата:2008
Автор: Gerber, G.
Формат: Стаття
Мова:English
Опубліковано: Інститут телекомунікацій і глобального інформаційного простору НАН України 2008
Теми:
Онлайн доступ:https://nasplib.isofts.kiev.ua/handle/123456789/19343
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Microbial environment, immunity and human health / G. Gerber // Екологічна безпека та природокористування: Зб. наук. пр. — К., 2008. — Вип. 2. — С. 5-50. — Бібліогр.: 140 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-19343
record_format dspace
spelling Gerber, G.
2011-04-27T18:05:36Z
2011-04-27T18:05:36Z
2008
Microbial environment, immunity and human health / G. Gerber // Екологічна безпека та природокористування: Зб. наук. пр. — К., 2008. — Вип. 2. — С. 5-50. — Бібліогр.: 140 назв. — англ.
XXXX-0062
https://nasplib.isofts.kiev.ua/handle/123456789/19343
Sophisticated analytical tools for elucidating genome structure and life of bacteria yielded a new paradigm on our relation to the microbial environment. Formerly, bacteria were seen as jeopardising invaders, and studies on bacterial pathogenesis were the basis for great medical progress in the restraint of infections. Now it becomes clear that Homo sapiens is not a single-species organism, but it is to understand as a complex ecosystem assembled of a 10:1 mixture of both environmental microbial and human cells.
en
Інститут телекомунікацій і глобального інформаційного простору НАН України
Екологічна безпека та природокористування
Екологічна безпека
Microbial environment, immunity and human health
Микробиологическая среда, иммунитет и здоровье человека
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Microbial environment, immunity and human health
spellingShingle Microbial environment, immunity and human health
Gerber, G.
Екологічна безпека
title_short Microbial environment, immunity and human health
title_full Microbial environment, immunity and human health
title_fullStr Microbial environment, immunity and human health
title_full_unstemmed Microbial environment, immunity and human health
title_sort microbial environment, immunity and human health
author Gerber, G.
author_facet Gerber, G.
topic Екологічна безпека
topic_facet Екологічна безпека
publishDate 2008
language English
container_title Екологічна безпека та природокористування
publisher Інститут телекомунікацій і глобального інформаційного простору НАН України
format Article
title_alt Микробиологическая среда, иммунитет и здоровье человека
description Sophisticated analytical tools for elucidating genome structure and life of bacteria yielded a new paradigm on our relation to the microbial environment. Formerly, bacteria were seen as jeopardising invaders, and studies on bacterial pathogenesis were the basis for great medical progress in the restraint of infections. Now it becomes clear that Homo sapiens is not a single-species organism, but it is to understand as a complex ecosystem assembled of a 10:1 mixture of both environmental microbial and human cells.
issn XXXX-0062
url https://nasplib.isofts.kiev.ua/handle/123456789/19343
citation_txt Microbial environment, immunity and human health / G. Gerber // Екологічна безпека та природокористування: Зб. наук. пр. — К., 2008. — Вип. 2. — С. 5-50. — Бібліогр.: 140 назв. — англ.
work_keys_str_mv AT gerberg microbialenvironmentimmunityandhumanhealth
AT gerberg mikrobiologičeskaâsredaimmunitetizdorovʹečeloveka
first_indexed 2025-11-25T21:31:27Z
last_indexed 2025-11-25T21:31:27Z
_version_ 1850558339491037184
fulltext 5 Ïðåðîìàíòèçì Ðîçä³ë 1. Åêîëîã³÷íà áåçïåêà ÓÄÊ 574/578(031) MICROBIAL ENVIRONMENT, IMMUNITY AND HUMAN HEALTH Gerber G. (Charité-Universitätsmedizin Berlin, Humboldt-Universität und Freie Universität Berlin, Alumni-Club der Charité, Augustenburger Platz 1; 13353 Berlin, Germany) Sophisticated analytical tools for elucidating genome structure and life of bacteria yielded a new paradigm on our relation to the microbial environment. Formerly, bacteria were seen as jeopardising invaders, and studies on bacterial pathogenesis were the basis for great medical progress in the restraint of infections. Now it becomes clear that Homo sapiens is not a single-species organism, but it is to understand as a complex ecosystem assembled of a 10:1 mixture of both environmental microbial and human cells. The gargantuan diversity of prokaryotic life includes genetic multiplicity, metabolic endowment, colonised habitats, and response to physical and chemical stresses. Advances in microbiology, molecular biology, biochemistry and eukaryotic cell biology have enabled striking discoveries on how eukaryotic cells cooperate with colonising bacteria. Bacterial life in multi- species associations and biofilms limits competition, reduces temporal variance of productivity, enhances performance, and favours positive interactions among the allied members. Quorum sensing, hypermutable loci in the genome, horizontal transfer of genes distributed within the population and the enduring crosstalk with the epithelia and the innate immune system of the host warrant stability within the microbial community and maintenance of the mutually beneficial association with the host. Factors accompanying our current life such as over- and malnutrition, physical inactivity, excessive use of tobacco, alcohol, drugs and medicine,  Gerber G., 2008 6 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ UV-irradiation, incorporation/inhalation of pesticides, toxic gases and heavy metals and growing-up in a sanitised world disturb the immune balance and the host-microbiota partnership. Phobia of germs, compulsive hygienic custom pattern, and the excessive use of antibiotic agents are detaining the immune system of the microbial information input upon which it is dependent. This conglomerate of factors and habits conforms to a huge increase of chronic inflammatory diseases, e.g. atherosclerosis, inflammatory bowel diseases, diabetes, asthma, rheumatism, neurodermatitis, psoriasis, adipositas, and cancer. It may be necessary to invent measures of replacing the microbial input. Food additives with immune modulating (e.g. beta-glucans), prebiotic (e.g. oligofructosides) or probiotic (e.g. Bifidus, Lactobacillus) features are anticipated to improve a tilted host-microbiota partnership, immunity and constitutional performance. Ñêëàäí³ àíàë³òè÷í³ ï³äõîäè äî âèâ÷åííÿ ñòðóêòóðè ³ æèòòÿ áàêòåð³é ïîðîäèëè íîâå â³äíîøåííÿ ùî äî ì³êðîáíîãî îòî÷óþ÷îãî ñåðåäîâèùà. Ðàí³øå ðîçãëÿäàëè áàêòå𳿠ÿê òàê³, ùî ñòâîðþþòü íåáåçïå÷í³ óìîâè äëÿ ³íøèõ îðãàí³çì³â, ³ äîñë³äæåííÿ ïàòîãåíåçó áàêòåð³àëüíèõ çàõâîðþ- âàíü áóëè îñíîâîþ äëÿ âåëèêîãî ïðîãðåñó â ìåäèöèí³ ùîäî ñòðèìóâàííÿ ³íôåêö³é. Çàðàç ñòຠçðîçóì³ëèì, ùî Ëþäèíà ðîçóìíà íå îêðåìèé îðãàí³çì, öå ñêëàäíà åêîñèñòåìà, ÿêà ñêëàäàºòüñÿ ó â³äíîøåíí³ 10:1 ç ð³çíèõ ì³êðîîðãàí³çì³â òà êë³òèí ëþäèíè. гçí³ ñåðåäîâèùà ³ñíóâàííÿ êîëîí³çóâàëè âåëè÷åçíå ãåíåòè÷íå ³ ìåòàáîë³÷íå ð³çíîìàí³òòÿ ïðîêàð³îò³â. Äîñÿãíåííÿ ó ì³êðîá³îëî㳿, ìîëåêóëÿðí³é á³îëî㳿, á³îõ³ì³¿ ³ öèòîëî㳿 åóêàð³îò³â äîçâîëèëè ç�ÿñóâà- òè, ÿê êë³òèíè åóêàð³îò³â âçàºìîä³þòü ç áàêòåð³ÿìè, ÿê³ êîëîí³çóþòü îðãàí³çìè.  àñîö³àö³ÿõ ð³çíîìàí³òíèõ áàêòåð³é îáìåæåíà êîíêóðåíö³ÿ, ñêîðî÷åíà ÷àñîâà ð³çíèöÿ ó â³äòâîðåíí³, âèíèêàþòü ïîçèòèâí³ âçàº- ìî䳿 ¿õ ÷ëåí³â ³ ñòèìóëþºòüñÿ ðîáîòà. ³ä÷óòòÿ «êâîðóìó», íàÿâí³ñòü ã³ïåðì³íëèâèõ ì³ñöü ó ãåíîì³, ãîðèçîíòàëüíèé ïåðåíîñ ãåí³â ì³æ áàê- òåð³ÿìè â ìåæàõ àñîö³àö³¿ òà ñò³éêèé âçàºìîçâ�ÿçîê ç åï³òåë³ÿìè òà ïðèðîäíîþ ³ìóííîþ ñèñòåìîþ õàçÿ¿íà ãàðàíòóþòü ñòàá³ëüí³ñòü ì³êðîáíîãî óãðóïóâàííÿ ³ âçàºìíî êîðèñí³ âçàºìî䳿. Ôàêòîðè, ÿê³ âïëèâàþòü íà íàøå æèòòÿ � ïåðå¿äàííÿ, íåäî¿äàííÿ, îáìåæåíà ô³çè÷íà àêòèâí³ñòü, íàäì³ðíå âæèâàííÿ òþòþíó, àëêîãîëþ, íàðêîòèê³â ³ ë³ê³â, óëüòðàô³îëåòîâîãî îïðîì³íåííÿ, ïàë³ííÿ, ä³ÿ êîìï- ëåêñó ïåñòèöèä³â, îòðóéíèõ ãàç³â ³ âàæêèõ ìåòàë³â, âèõîâàííÿ ä³òåé ó ñàíîâàíîìó ñâ³ò³ � ïîðóøóþòü ³ìóííèé áàëàíñ ³ âçàºìîä³þ îðãàí³çìó õàçÿ¿íà ç áàêòåð³ÿìè. Áîÿçíü ì³êðîá³â, ñóâîð³ íàâ�ÿçëèâ³ ã³ã³ºí³÷í³ âèìî- ãè ³ íàäì³ðíå çàñòîñóâàííÿ àíòèá³îòèê³â çàòðèìóº ðîçâèòîê ³ìóííî¿ ñèñòåìè, òîìó ùî áàãàòî ì³êðîîðãàí³çì³â íå ïîòðàïëÿþòü â îðãàí³çì ëþäèíè. 7 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Öåé íàá³ð ôàêòîð³â ³ çâè÷îê â³äïîâ³äຠâåëè÷åçíîìó çá³ëüøåííþ õðîí³÷íèõ çàõâîðþâàíü, ÿê³ ìàþòü âàæêè íàñë³äêè, íàïðèêëàä, àòåðî- ñêëåðîçó, õâîðîá øëóíêîâî-êèøêîâîãî òðàêòó, ä³àáåòó, àñòìè, ðåâìà- òèçìó, íåéðîäåðì³ò³â, ïñîð³àçó, ðàêó. Ìîæëèâî òðåáà çàïðîïîíóâàòè íîâ³ çàñîáè çàì³íè âïëèâó ì³êðîîðãàí³çì³â , íàïðèêëàä, âèêîðèñòîâóâà- òè õàð÷îâ³ äîì³øêè, ÿê³ ì³ñòÿòü ³ìóíîìîäóëÿòîðè (íàïðèêëàä, áåòà- ãë³êàíè); ïðåá³îòèê³ (íàïðèêëàä, îë³ãîôðóêòîçè) àáî ïðîá³îòèê³ (íà- ïðèêëàä, Áèôiäîáàêòåð³¿, Ëàêòîáàêòåð³¿). ª ñïîä³âàííÿ, ùî ¿õ çàñòîñóâàííÿ ïîêðàùèòü âçàºìîä³þ ì³êðîîðãàí³çì³â ³ ëþäèíè, ¿¿ ³ìóí³- òåò ³ ñòàëó ðîáîòó ¿¿ îðãàí³çìó. Ñëîæíûå àíàëèòè÷åñêèå èíñòðóìåíòû, îáúÿñíÿþùèå ñòðóêòóðó è æèçíü áàêòåðèé, ïðèâåëè ê íîâîìó îòíîøåíèþ ê ìèêðîáíîé îêðóæàþùåé ñðåäå. Ïðåæäå áàêòåðèè ðàññìàòðèâàëè êàê òàêèå, êîòîðûå ñîçäàþò îïàñíûå óñëîâèÿ äëÿ äðóãèõ îðãàíèçìîâ, à èññëåäîâàíèÿ áàêòåðèàëüíîãî ïàòîãåíåçà áûëè îñíîâàíèåì äëÿ áîëüøîãî ìåäèöèíñêîãî ïðîãðåññà â ñäåðæèâàíèè èíôåêöèé. Òåïåðü ñòàíîâèòñÿ ÿñíî, ÷òî ×åëîâåê ðàçóìíûé íå îòäåëüíûé îðãàíèçì, à ñëîæíàÿ ýêîñèñòåìà, ñîñòîÿùàÿ â îòíîøå- íèè 10:1 èç ðàçíûõ ìèêðîîðãàíèçìîâ è ÷åëîâå÷åñêèõ êëåòîê. Ðàçíûå ñðåäû îáèòàíèÿ êîëîíèçèðîâàëè ãèãàíòñêîå ãåíåòè÷åñêîå è ìåòàáîëè÷åñêîå ðàçíîîáðàçèå ïðîêàðèîò. Äîñòèæåíèÿ â ìèêðîáè- îëîãèè, ìîëåêóëÿðíîé áèîëîãèè, áèîõèìèè è öèòîëîãèè åóêàðèîò ïî- çâîëèëè ïîêàçàòü êàê êëåòêè åóêàðèîò ñîòðóäíè÷àþò ñ êîëîíèçèðó- þùèìè îðãàíèçì áàêòåðèÿìè.  àññîöèàöèÿõ ðàçíîîáðàçíûõ áàêòåðèé îãðàíè÷åíà êîíêóðåíöèÿ, ñîêðàùåíà âðåìåííàÿ ðàçíèöà âîñïðîèçâîä- ñòâà, âîçíèêàåò ïîëîæèòåëüíîå âçàèìîäåéñòâèå èõ ÷ëåíîâ è ñòèìó- ëèðóåòñÿ ðàáîòà. Îùóùåíèå «êâîðóìà», ãèïåðèçìåí÷èâûå ìåñòà â ãåíîìå, ãîðèçîíòàëüíûé ïåðåíîñ ãåíîâ ìåæäó áàêòåðèÿìè â ïðåäåëàõ àññîöèàöèè è óñòîé÷èâàÿ ñâÿçü ñ ýïèòåëèÿìè è âðîæäåííîé èììóííîé ñèñòåìîé õîçÿèíà ãàðàíòèðóåò ñòàáèëüíîñòü ìèêðîáíîãî ñîîáùå- ñòâà è âçàèìíî ïîëåçíîãî âçàèìîäåéñòâèÿ. Ôàêòîðû, ñîïðîâîæäàþùèå íàøó òåêóùóþ æèçíü, òàêèå êàê ñâåðõ- èëè íåäîåäàíèå, ôèçè÷åñêàÿ áåçäåÿòåëüíîñòü, ÷ðåçìåðíîå èñïîëüçîâà- íèå òàáàêà, àëêîãîëÿ, íàðêîòèêîâ è ëåêàðñòâ, óëüòðàôèîëåòîâîå îáëó- ÷åíèå, äåéñòâèå êîìïëåêñà ïåñòèöèäîâ, ÿäîâèòûõ ãàçîâ è òÿæåëûõ ìåòàëëîâ è âîñïèòàíèå äåòåé â ñàíèðîâàííîì ìèðå íàðóøàþò èììóí- íûé áàëàíñ è âçàèìîäåéñòâèå îðãàíèçìà õîçÿèíà ñ áàêòåðèÿìè. Áîÿçíü ìèêðîáîâ, ñòðîãèå íàâÿç÷èâûå ãèãèåíè÷åñêèå òðåáîâàíèÿ è ÷ðåçìåðíîå èñïîëüçîâàíèå àíòèáèîòèêîâ çàäåðæèâàåò ðàçâèòèå èììóííîé ñèñòå- ìû, ò.ê. ìíîãèå ìèêðîîðãàíèçìû íå ïîïàäàþò â îðãàíèçì ÷åëîâåêà. Ýòîò íàáîð ôàêòîðîâ è ïðèâû÷åê ïîðîæäàåò îãðîìíîå óâåëè÷å- íèå õðîíè÷åñêèõ áîëåçíåé, êîòîðûå èìåþò òÿæåëûå ïîñëåäñòâèÿ, 8 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ íàïðèìåð, àòåðîñêëåðîçà, áîëåçíåé êèøå÷íèêà, äèàáåòà, àñòìû, ðåâ- ìàòèçìà, íåéðîäåðìèòîâ, ïñîðèàçà, ðàêà. Ìîæåò áûòü íåîáõîäèìî ïðåäëîæèòü íîâûå ìåòîäû çàìåíû âëèÿíèÿ ìèêðîîðãàíèçìîâ, íàïðè- ìåð, ïèùåâûìè äîáàâêàìè, ñîäåðæàùèìè èììóíîìîäóëÿòîðû (íàïðè- ìåð, áåòà-ãëèêàíû), ïðåáèîòèêè (íàïðèìåð, îëèãîôðóêòîçû) èëè ïðî- áèîòèêè (íàïðèìåð, Áèôèäîáàêòåðèè èëè Ëàêòîáàêòåðèè). Êàê îæèäàþò, èõ ïðèìåíåíèå óëó÷øèò âçàèìîäåéñòâèå ìèêðîîðãàíèçìîâ è ÷åëîâåêà, åãî èììóíèòåò è ñòàáèëüíóþ ðàáîòó åãî îðãàíèçìà. 1. Microbial diversity and human activity Fifteen hundred scientists under the auspices of the United Nations Environment Programme (UNEP) completed in 1995 the Global Biodiversity Assessment (Heywood 1995). This appraisal alludes to the biological diversity at all levels � genes, species, and ecosystems � and is still extremely uncertain. Of its working figure of 13 million species, only approximately 1.7 million have been scientifically described and given Linnaean nomenclature. These living organisms interact among them and with the non-living environment and comprise the global ecosystems. The biological multiplicity is pivotally evident for human society and sustainable development. A reckoned 40 per cent of the global economy rests upon biological products and processes. Faced with the rate of species extinctions, which is hundreds or thousands of times the natural background level, the public begins to raise attention on the outcome of human activities on biodiversity. However, the appreciation on how activity of mankind, human health and biodiversity are intimately connected among one another will only increase in coming years. Having a glance in a biology textbook of the 1980s one may realise that the living matter is subdivided in five kingdoms: Bacteria, Protoctista (nucleated unicellular organisms), Fungi, Plantae and Animalia. About 5000 species classified by means of traditional bacteriological techniques were allocated to non-eukaryotic organisms, and thus should contribute only a minor portion to the overall species variety (Skerman et al. 1989). Just for comparison: more than half a million insect species have been classified. Beginning in the 1960s it became feasible to define prokaryotes on the basis of shared molecular characteristics when Zuckerkandl and Pauling (1965) expounded the role of nucleic acid as the master 9 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà candidate of a molecular phylogeny. Obviously, microbial morphology, motility, metabolism and serological types are too simply or inexplicable to serve as the basis for a phylogenetically compelling taxonomy. Sophisticated techniques such as reverse transcription (RT)-PVR, DNA micro arrays, in vivo expression technology (IVET), fluorescence in situ hybridisation (FISH), restriction fragment length polymorphism, subtractive hybridisation, signature-tagged mutagenesis, in situ isotope tracking, and the sequencing revolution replaced classical phenotypic characteristics by molecular criteria. This progress culminated in two scientific acmes at the end of the last century: i) the creation of a new natural system of organisms dividing life on our planet in three domains (Woese et al. 1990), and ii) the whole-genome random sequencing and assembly of a free-living microorganism, the ã-proteobacterium Haemophilus influenzae Rd. (Fleischmann et al. 1995). Comparison of the unique sequences of nucleobases in the chromosomes has all of a sudden shown that the three primary domains are: Bacteria, Archaea, and Eukarya. These domains evolved in parallel along three phylogenetic lineages. The small unit of ribosomal ribonucleic acid (16S rRNA from prokaryotic cells and 18S rRNA from eukaryotic cells) proved to be an elegant taxonomic tool in regard of the following: first, it is present in all organisms, and secondly, it contains highly conserved as well as variable nucleotide sequences. Divergence between species or strains may be evident when comparisons are made of the variable regions, and comparing highly conserved regions may elucidate divergence at the higher taxonomic ranks (domain, kingdom). Nowadays, techniques for high-throughput cultivation of more than 10,000 bacterial and fungal isolates per environmental sample are available (Zengler et al. 2002). That provides access to the immense reservoir of untapped microbial diversity by cultivation. Determination the species composition of a microbial community needs to be followed by establishing the functions of the community and of each of its members (metabolic fingerprinting by community level physiological profiling CLPP). After all, one has to have in mind that there is an ongoing debate on methods for defining species, mechanisms that lead to speciation and whether microbial species even exist. Achtman and Wagner (2008) propose that a method-free species concept based on cohesive evolutionary forces should direct decisions on the existence of species and procedures to define them. 10 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ From a commonplace of view we recognise only the multicellular creatures as the denizens of our earth. All are Eukarya, but many single- cellular belong to this domain, too. Bacteria and Archaea are exclusively composed of prokaryotic cells and are thus microbial. The major advances in molecular and cell biology and the application of these methodologies on microbiology produced cross-fertilisation of these disciplines and had impacts, which was unimaginable only a generation ago (Table 1). The gargantuan diversity of prokaryotic life includes genetic multiplicity, metabolic endowment, colonised habitats, and response to physical and chemical stresses. Microorganisms are the major life forms on earth and reside yet in extreme environments like very rocks, hot springs and submarine grounds. The amount of carbon that is piled up in prokaryotes matches that in the plant kingdom. In case of nitrogen and phosphorus the ratio is even ten in favour of the microbes. Since only less than 1% of species of the microbial world was cultivated and studied under laboratory conditions, we know nothing of them other than what can be inferred from their genomic sequence. The majority of microorganisms lives in microbial dynamic assemblages. The stability and functions of these consortia are ruled by dependencies and antagonisms among the members. Life in multi-species associations and biofilms limits competition and favours positive interactions among the allied bacteria. A fraction of the microbial universe coexists with animals in mutually beneficial association. Such microbial communities have to assert themselves with the vicissitudes of their host (Handelsman et al. 2005). Microbial symbioses with animals warrant benefits to both host and bacteria and promote their macro-evolutionary persistency. Such symbioses have played an essential role in revival of the biosphere after periodic mass annihilation of major groups of organisms and whole ecosystems (Hickman 2005). Less than 0.0005 percent of the total domain Bacteria can cause disease. The relation in fungi is not quiet different: approximately 300 of the greater than 100,000 classified fungal species have pathogenic relationships with animals and plants (Steenbergen and Casadevall 2006). Advances in microbiology, molecular biology and eukaryotic cell biology have enabled striking discoveries on how eukaryotic cells cooperate with colonising bacteria and interact with pathogens during the infectious process. The partnering-up of these related fields progressed in a novel scientific discipline that has been termed cellular microbiology (Cossart et al. 1996). 11 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Topics Impact References Diversity of prokaryotic life Genetic diversity highest in the microbial world, prokaryotes encompass up to ten million species, wide range of energy substrates and the availableness of miscellaneous catabolic and anabolic pathways, occupying multiple habitats, multitude of responses to physical and chemical stresses Stahl and Tiedje 2002 Torsvik et al. 2002 Ancestry Eukarya, Bacteria and Archaea have split from a common ancestor 2—3.5 billion years ago Woese et al. 1990 Doolittle et al. 1996 Biomass 4—6×1030 prokaryotic cells on earth containing 350—550×109 tons of carbon, 85—130×109 t nitrogen, 9— 14×109 t phosphorus, cellular production rate for all prokaryotes on earth is estimated at 1.7×1030 cells/yr, it is highest in the open ocean Whitman et al. 1998 Cultivability 90 to 99.9 % do not grow and replicate in cultures under laboratory conditions Henderson et al. 1999 (p.19) Mode of life Multi-species associations, colonies, biofilms, quorum sensing systems as signal amplifiers within a bacteria and as signal disseminators between bacteria Palmer et al. 2007 Fuqua et al. 1994 Dunny and Winans 1999 Symbiosis 1000—3000 species (phylotypes) mutually coexist with man, specific gene-gene interactions within the microbiome (genomic plasticity) Eckburg et al. 2005 Dethlefsen et al. 2007 Ehrlich et al. 2008 Pathogenicity About 50 bacteria cause human diseases Rappuoli 2006 Table 1 � Impact of new analytical tools on cellular microbiology The current debate on the use and misuse of antibiotics perpetuates a long history of semantic thoughts on microbes as friend or foe of man. In the late seventieth century, Antonie van Leeuwenhoek, who ranks first to had inspected the indiscernible minuscule life, already expressed his astonishment on the ample colonisation of our body and its environment by «animalcule» what means «little animals»: «�there are more animals 12 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ living in the scum on the teeth in a man´s mouth, than there are men in the whole kingdom». Bacteriology started two centuries later with the pioneering work of Robert Koch, Louis Pasteur, Sergei Winogradsky and other scientific heroes. Koch and Pasteur developed pure culture techniques to identify causative agents of many diseases that affect humans and animals. Contrariwise, Sergei Winogradsky � born in Kiev 1856 � invented a simple columnar device for culturing a large diversity of bacterial life in natural environments. Among the bacteria within such a single column there grow members of all four basic life strategies: phototrophs, chemotrophs, autotrophs, and heterotrophs. The Winogradsky column evolved, thus, as classic tool for studying the relationships between different types of microorganisms in mixed communities. In addition, it is an elegant illustration of how microorganisms occupy highly specific niches according to their environmental tolerances and their requirements of energy and carbon. In the aftermath microbes were dichotomic seen from the viewpoint of practical purposes (Gutzeit 1918, Duddington 1961). The «good» ones help in fermentations in the dairy industry, the manufacture of vinegar, beer, coffee, cocoa, food supplements, and feed for farm animals as well as in biomining (bioleaching) and sewage treatment. The «bad» ones are looked upon as pests or can be at least a nuisance in many everyday situations. According to the widely held opinion, germs should be eliminated or constrained in their activities. Following such options many a scientist lumbered in a meander. Ilja Metchnikoff, for example, assumed «autointoxication» of the human body by the intestinal microflora and practised surgical ablation of the colon. Later, however, by contemplating about longevity in Bulgarians he suggested that that may be linked to the helpful activity of lactic acid bacteria ingested with sour milk. The elimination of bacterial pathogens appeared to become a reality when antimicrobial agents were introduced into clinical practice in the 1940s and 1950s. That was one of the most outstanding public health achievements of the 20th century. In marvelling the unimaginable aid to legions of infected patients the Western societies lost its fear of bacterial infection. In 1969 the then United States Surgeon General presumed to prophesy in his address to Congress «We can close the book on infectious diseases». One outcome of this misjudgement was the drop in research into the mechanisms by which bacteria cause communicable diseases. The other was the assumption on the selective 13 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà toxicity of a particular antibiotic to a certain bacterial pathogen: due to fundamental differences to eukaryotic cells the antibiotic therapy might not threat the host. Nonetheless, already in the late 1940s strains of Staphylococcus aureus developed resistance against penicillin. The number increased steadily and at present MRSA (methicillin-resistant Staphylococcus aureus) is a menace of hospital settings. Resistance has developed meanwhile against all available classes of antibiotics (Virk and Steckelberg 2000, Smith and Coast 2002). Rowe-Magnus and Mazel (2006) published a survey on the evolution, biochemical mechanisms of antibiotic resistance and their genetic determinants. Species of the genus Bacteroides have the highest resistance rates of all anaerobic pathogens, the multiple mechanisms of which are discussed by Wexler (2007). In addition, there are alert marks just heralding man-made tumbling into a new predicament: Resistant Staphylococcus aureus changed its epidemiology and advanced from being a pathogen primarily related with nosocomial infection to one that has begun to recurrently infect individuals outside the hospitals (Chambers 2001). Obviously the «golden age of antibiotics» turns up jaded after merely two generations. By traditional view, the transmission of pathogenic bacteria has been assumed to take place through ingestion of infected stuff or liquids and intimate contact with contaminated surfaces. Transmission over short distances is also possible when the pathogen is enclosed in large droplets, as in sputum. This route should be rendered more precisely on the basis of reports on airborne transmission of communicable diseases (Roy and Milton 2004). Gandara et al. (2006) gave account on the common appearance of cultivable strains of Staphylococcus aureus resistant against penicillin, ampicillin and cefaclor in aerosols sampled within residential homes. The infection of children without known risk factors with this pathogen has to be regarded as an exceptionally precarious observation (Gorak et al. 1999). Experiments on mouse and human cell lines demonstrate the ability of indoor air bacteria and fungal spores in boosting the production of proinflammatory mediators (Huttunen et al. 2003). The trends in the epidemiology of antibiotic-resistant pathogens give persuasive justification for more profound scientific exploration of both the indoor sources of, and morbid effects correlated with, indoor residential exposure to airborne pathogens. 14 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Findings emphasise that current concentrated animal feeding operations (CAFOs) can result among others in the emanation of antibiotic- resistant bacteria into the general environment (Platz et al. 1995). Multiresistant strains were detected in the air plume up to 150 m downwind of a swine confined animal feeding operation (Gibbs et al. 2006). Naïve subjects living in close proximity to such facilities and employees who work inside suffered from respiratory inflammatory symptoms (Heederick et al. 2007). The paucity of data in regard of environmental and community adverse health effects of modern production of pigs and poultry resulted in a growing controversy in the public (Cole et al. 2000, Rieger 2001). Intensified cooperation among animal producers, feed professionals and health officials as well as forced research in cross-linked human and veterinary health surveillance systems are indispensable to successfully address these issues. Special attention should be given to high-risk groups such as children and asthmatics. A flicker of hope comes from Denmark, where the prevalence of macrolide-resistant species of Campylobacter dropped subsequently to the banning of all growth promoters from feeding in livestock. 2. Man and microbes are companions Microbes make up a considerable component of the human body. The external surface � like the skin and its adhering structures � and the internal surfaces such as the mucosal layers of the gastrointestinal, respiratory and genito-urinary system and the cavities they enclose, harbour microbial communities of different complexity. The term microbiota, or indigenous microflora, or commensal microflora, respectively, encompasses all of the bacteria, archaea, fungi, proctists, and viruses. The bacterial component at any body site was chiefly studied, but little is known about the other types. The microbiota in the adult has a mass of about 1�2 kg, which corresponds to that of liver and outruns most other human tissues. Although this represents only about 2% of the whole body mass, in terms of cell numbers the total microbial population exceeds our total number of somatic and germ cells by at least one order of magnitude (Xu and Gordon 2003). The number of genes in this «microbiome» may overtake the human genome about 100 times. In conclusion, human sapiens may not be regarded as a single-species organism, but as a complex ecosystem 15 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà compiled of a 10:1 mélange of both microbial and human cells (McVean et al. 2005, Eckburg et al. 2005, Ley et al. 2006). The microbiome and hosts genome collectively constitute the hologenome that includes all genes from the host and from all symbionts. It is flexible and varies with age, health, diet, and environmental factors. The 6.5 billion humans living on earth represent a microbial reservoir of 1023�1024 prokaryotic cells. Thus, human intestine and that of other mammals share a considerable portion of the total microbial mass on our planet that is estimated to about 4�6×1030 prokaryotic cells. The human bowel harbours 1011�1012 prokaryotic cells per ml, the highest observed density for any microbial habitat (Whitman et al. 1998). During foetal life the human being like all other mammals dwells in a sterile environment. Birth is the encounter stage in microbial colonisation of the newborn that discharges into a life-long partnership. First microbes stem from the mother, members of clinical staff, equipment and the close environment. Later, germs may attain from more distant sites of environment and from food. One may wonder in all innocence what causes the whittling down of a spectrum of more than fifty phyla of Bacteria and 13 phyla of Archaea staying alive on earth to just four phyla of Bacteria � the Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria � that overwhelmingly dominate microbial communities of man. In the colon Bacteroidetes and Firmicutes contribute more than 95% of the microbiota, only one member of Archaea (Methanobrevibacter smithii) is present? Chlamydiae, Cyanobacteria, Deferribacteres, Deinococcus-Thermus, Fusobacteria, Verrucomicrobia, and Spirochaetes establish the minor balance. High levels of strain variation complete this little dissimilarity in the deep phylogenetic lineages. That type of an extreme fan-like phylogenetic architecture of the gut microbiota might have arisen in evolution from the diversification of a distinct limited primary community into strains (Ley et al. 2006). A more detailed view of the differences between genomes of human individuals and the microbiota may foreshadow a deeper comprehension on evolutionary and biological forces that have made us (Dethlefsen et al. (2007). Apparently there are stringent requirements for membership in the microbial community. Whether or not a bacterium affiliates the local biota depends on the nutritional and physicochemical conditions and the host defence on site. It obeys two fundamental rules formulated by Liebig and Shelford. The nutrient present in the lowest concentration 16 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ in comparison with the needs of the organism determines the yield of this organism according to Liebig´s law of minimum. Usually the host and accompanying microbes are the sources of nutrients, intestinal microbes utilise in addition ingested foodstuffs. Shelford´s law states that each of the physicochemical constraints operating on site have to remain within the tolerance range to make available the survival of a species within an ecosystem. The effectiveness of these basic laws is amended by beneficial and antagonistic interactions among the species present, colonisation history, host characteristics (genotype, age, gender, life-style, diseases). The dual hegemony of Firmicutes and Bacteroidetes apparently originates from their particular and complementary metabolic functions within the microbial community. The «living-together» is variable with respect to species and topological distribution of microbes involved and the mode of cooperation with the host. The biochemical features of binding and identification of molecules determine the rules of pacing, extent, and pattern of microbial diversity. Different methodologies employed, variation between individuals, changes in microbial nomenclature and taxonomy, and so on hamper the compilation of published data on the distribution of particular fractions of microbes. Nonetheless, an approach is made to survey the diversity of indigenous microbiota in various sites of adult humans (Table 2). Most of the data on the microbiota still have been derived from culture-based investigations. However, cultivation methods under-represent the extent of bacterial diversity. For instance, in samples from human microbiota about 10�50% of bacteria can cultivated, from environments (soil, lakes, seawater, sediments) less than 1%. In spite of evident variations in tissue structural and functional properties of our outer and inner surfaces and environmental determinants, each microbial community is generally dominated by a limited number of species. Only five phyla contribute more than 90% and establish the core set of regional microbiotas. That was shown for the oral cavity, the distal oesophagus, the stomach, and the colon, where Actinobacteria, Firmicutes, Proteobacteria, Bacteroidetes and Fusobacteria are dominating. It holds to be true for skin, too, though Fusobacteria are missing there. Infrequent taxa compose the remainder of the population and may vary between times of sampling and among individuals. The density of sudoriferous (sweat-producing) and sebaceous (sebum- producing) glands at the particular area principally influence the 17 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Body site Number Diversity Bacteria 1 2 3 4 Skin, hairfollicle 103 -106 per cm2 Stable scaffold of small number of genera Actinobacteria, Firmicutes, Proteobacteria, Corynebacterium, Staphylococcus, Streptococcus, Propionibacterium, Micrococcus, Kocuria, Malassezia, Brevibacterium, Dermabacter, Acinetobacter, Methylobacterium Conjunctiva of eye 102 - 5x104 Usually not more than 2 species CNS (coagulase negative staphylococci), Propionibacteria, Corynebacterium, Streptococcus, Lactobacillus, Sarcina, Bacillus Oral cavity 108 per ml saliva 107-109 per cm2 tongue High Firmicutes, Bacteriodetes, Streptococcus, Actinomyces, Neisseria, Haemophilus, Eubacterium, Lactobacillus, Fusobacterium, Abotriophia, Gemella, Veillonella, Prevotella, Bifidobacterium, Staphylococcus, Propionibactrium, Porphyromonas Plaques: Streptococcus mutans, Streptococcus viridans, Actinomyces, Veillonella, Fusobacterium, Prevotella, Eubacterium, spirochaetes Porphyromonas gingivalis, Bacteroides forsythus, and Treponema denticola Gastro- intestinal tract 1014 1011 – 1012 cells per ml Upper part: low Lower part: high Oesophagus: Staphylococci, lactobacilli, Corynebacterium, Prevotella, Veillonella. Stomach: Hel. pylori, acid-tolerant streptococci, staphylococci and lactobacilli. Ileum: Streptococci, enterococci and coliforms in the lumen; on the mucosa Bacteroides, Clostridium, Table 2 � Indigenous microbiota at various sites of human body 18 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Compiled from Paster et al. (2001), Wang et al. (2003), Pei et al. (2004), Eckburg et al. (2005), de Backer et al. (2007), deFranco et al. (2007), Dethlefsen et al. (2007), Gao et al. (2007), Wilson (2008). Body site Number Diversity Bacteria 1 2 3 4 Bifidobacterium. Cecum: Enterobacteriacea, lactobacilli, Bacteroidetes, Clostridium. Colon: Bacteroides, Eubacterium, Bifidobacterium, Clostridium; (by culture-independent methods: Firmicutes, Bacteroidetes, Clostridia, Bifidobacterium, Atopobium) Respiratory tract Upper part: high Lower part: no resident microflora Streptococcus, Neisseria, Haemophilus, CNS, Corynebacterium, Propionibacterium, Prevotella, Veillonella, Mollicutes. Microbes detectable in the lung, which are aspirated with microbe- containing secretions from the upper respiratory tract Female reproductive system 109 High <4—8 per individual Lactobacilli, CNS, Gram-negative anaerobic bacilli (GNAB), Gram- positive anaerobic cocci (GPAC), Corynebacterium, Bacteroides, Prevotella, Gardnerella vaginalis, Atopobium vaginae composition of cutaneous microbiota. Corynebacterium, Propionibac- terium, and Staphylococci inhabit at any site, propionibacteria dominate sebum-rich sites (forehead, scalp), corynebacteria moist areas (axillae, perineum), and staphylococci are the predominating species in dry regions such as arms and legs. Microbial communities inhabit nose and the pharynx, where they adhere to a substratum in order to prevent 19 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà expulsion by the respiratory flow. This region is a carriage site of a number of very important human pathogens (Strep. pyogenes, Strep. pneumoniae, H. influenzae, Staph. aureus, N. meningitides). The airways in the lungs are sterile to a large extent. The gastrointestinal tract expanding from the oral cavity until colon and rectum is highly diverse from anatomical, functional and microbial points of view. With a surface of 200�300 m2 it is the largest body surface in contact with the environment. About 700 bacterial phylotypes have been characterised in the oral cavity with considerable variations between various sites. Besides of the densely colonised tongue the teeth are the predominant area in this location. Bacteria on tooth surfaces live in biofilms that are known as plaques. Adhering to these surfaces is of pivotal significance for any potential microbial coloniser, since in this cavity biting, chewing, tongue movements, and salivary flow generate the highest mechanical forces in the body and the danger of displacement. «Pioneer colonisers» such as Actinomyces equipped with adhesins start colonisation of tooth�s surface followed by biofilm- promoting Streptomyces. «Secondary colonisers», unable either to adhere, or survive on the bare tooth surface, join expansion to the plaque by autogenic growth. The largest assembly of microorganisms undoubtedly inhabit the intestine. Most are refractory to cultivation. Physicochemical and nutrient gradients exist along the gut and in the transversal direction of the lumen. This and the complex microstructure of epithelia and the mucous layer on their exterior as well as the high rate of cell renewal make available many niches for microbial existence. So extreme species diversity (up to 1,000 species), inter-subject variability and differences between anatomical and microanatomical locations might be not astonishing (Eckburg et al. 2005). Nevertheless, a few generally consistent traits appear evident (Table 3). The part of the body that is beneath the skin and the mucosal epithelia is devoid of microorganisms. Therefore, one function of epithelia is to prevent contact of the microbes with the rest of the body. This is realised in various modes (Fig. 1): Several junctions (tight junctions, zonula adherence, desmosomes) link epithelial cells with each other and with the underlying connective tissue matrix to establish a physical barrier. A coat of keratinised dry and dead horny cells, which are not accessible for microbes, further protects the skin. Special 20 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Table 3 � Characteristic traits of the intestinal microbiota Trait Property and function of gut microbiota Reference Biodiversity Restricted by stringent requirements for membership in the microbial community: - enzymes to utilise available nutrients - cell-wall accessories to contact the proper habitat and to conciliate the supervising immune system, - evade bacteriophages, - fast growing to prevent washout, - mutability to be able to adaptation - stress resistance in order to leap to other hosts overcoming an awkward or toxic environment Ley et al. 2006 Share of anaerobes > 99.9% of the cultivable population in adults are obligate anaerobes Moore and Holdeman 1974 Bifidus spp. Dominating in the preweaning microbiota, in particular Bifidobac- terium longum with high activities of ß-galactosidases to utilise lactose of mothers milk Schell et al. 2002 Regional population density Increases from the duodenum containing 103 cfu/ml (that is 103 organisms per ml luminal contents) to the colon with 1011 cfu per ml contents. Thus, it increases by about 8 orders of magnitude along the gut Savage 1977 Involvement in host metabolism Microflora operates as a postnatally acquired, multifunctional autochthonous organ, metabolic diversity by far outperforms that of human tissues, complements the metabolism of host, e.g. cracking of indigestible polysac- charides of plant or microbial origin, degradation of dietary oxalates, bio- transformation of conjugated bile acids, synthesis of vitamins and amino acids Salmond et al. 1995 21 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Trait Property and function of gut microbiota Reference Immunity Coaching the immune system tolerance against a wide mix of environmental and food antigens, decreases number and extent of allergic responses Braun-Fahrländer et al. 2002 Intestinal epithelia Maintenance of intestinal epithelial homeostasis, protecting epithelial cell layers and stimulating the development of intestine´s elaborate submucosal network of interconnected capillaries Rakoff-Nahoum et al. 2004, Stappenbeck et al. 2002 Fat storage in host Decreases lipid accumulation in adipose tissue, increases lipid mobilisation, prevents adiposity Ley et al. 2005, Bäckhed et al. 2007 glycoproteins (mucins) secreted by the epithelium prevent mucosal surfaces from microbial sticking. One part, the membranous mucins are fixed to the cells and form the «glycokalyx». Secreted mucins form large linked polymers that are closely associated with the glycokalyx. The epithelium secretes microbicidal peptides, and local B cells secrete IgA. M-cells conduct transport of intact macromolecules from the lumen to the opposite side by an endocytose mechanism. The most remote cells on the top of the villus are regularly being expelled and are thrown out together with mucus and attached microbes. 22 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Figure 1. Physicochemical and immune barriers against microbial invaders. TJ = Tight junction; ZA = Zonula adherence; DE = Desmosom. = Immunoglobulin A attacking pathogen microbes 23 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà 3. Stabilisation of the microbiota The microbiota may maintain sustainable stability by two mechanisms: firstly, by interactions among the members of the microbial population, and secondly by interaction with the host. The general types of interactions between microbial species are shown in the Table 4. These might be positive or negative for the members involved that means beneficial for survival or extinction, respectively. It should be noted that there is some confusion with respect to the term «symbiosis». Now and then it is used to characterise an exclusively beneficial cooperation such as synergism or mutualism. But, strictly speaking, it bears on any long-term relationship between two populations. Several mechanisms that may be involved in gut stability are suggested in the Table 5. From the viewpoint of system biology species richness insures ecosystems against functional failure since various species give a better warranty that some will maintain functioning even if others fail. An understanding of long-term effects of biodiversity on ecosystem processes may be given by the insurance hypothesis (Yachi and Lereau, 1999). These authors developed a general stochastic dynamic model to assess the effects of species richness on the productivity of the ecosystem, based on individual species� productivity responses to environmental fluctuations. The model shows two major insurance effects: i) a buffering effect, i.e., a reduction in the temporal variance of productivity, and ii) a performance-enhancing effect, i.e., an increase in the temporal mean of productivity. This and other models were designed to predict the «pure» effects of species richness by randomising and averaging across perturbing environmental factors. Later on Norberg et al. (2001) developed a more realistic, yet general, model linking diversity and ecosystems functioning by modelling the means and variances of phenotypes within a group of species. The presented framework suggests that phenotypic variance within functional groups is linearly related to their ability to respond to environmental changes. Most intriguing is the ratio between short- term productivity with low variance and fixed optimal phenotypes, and long-term productivity in changing environments with higher phenotypic variance. The adaptive model had a higher productivity than the model with a fixed phenotype. The contribution of Norberg et al. is a 24 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Table 4 � Type of interactions between two microbial populations A and B A B A B Commensalism + 0 Supplies vitamins and amino acids, degrades polymers to monomers, solubilisation of insoluble compounds, neutralisation of toxic substances Utilises essential substances that it is not able to synthesise, utilises monomers, utilises solubilised compounds, protects against toxic substances Synergism + + Syntrophism (Cross-feeding, food chains, food webs) Bacteroides produces sulphate, Ent. faecalis converts arginine to ornithine and utilises putrescine Desulfovibrio utilises essential sulphate, E. coli converts ornithine to putrescine that can be further utilised by this species Mutualism + + A form of synergism in which the relationship between the two organisms is obligatory Competition - - Competitve exclusion E. coli and Clostridium difficile compete on certain sugars methanogens and sulphate-reducing bacteria compete on H2 Amensalism + - Produces toxic substances: bactericins, hydrogen peroxide, acidic end products Cessation of growth and killing in an incompatible environment (Candida unable to grow on skin and vagina owing to low pH) Parasitism + - Protoctists Entamoeba gingivalis in the oral cavity, Dientamoeba fragilis in the intestine Bacteria are the major food for protoctists 25 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Table 5 � Mechanisms of maintaining stability in the intestinal microbiota persuasive affirmation of linking diversification, abundance and evolution as bolstered by Darwin in 1859. There is now expanding belief that microbes of a single species or a number of different species aggregate to communities of different complexity in the colon and other sites. That encompasses individual cells attached to a surface, loosely aggregated microcolonies as well as biofilms. Four decades ago Guggenheim and Schroeder (1967) observed aggregation and clumping of Streptococcus mutans a few seconds after addition of sucrose into the incubation medium. Formation of high- molecular dextran was surmised to be responsible for this effect, which was soon confirmed experimentally by Gibbons and Fitzgerald (1969). Dextran binds receptor molecules on the bacterial surface and links cells to a network. These findings were conjectured as of clinical relevance for cariogenic plaque formation and may be seen as the first report of elucidation of specific macromolecular interactions to the phenomenon what we now know as biofilm. Probert and Gibson (2002) allude to experimental research on microbial biofilms already in 1936. A biofilm is apprehended as a community of surface-adherent Factor Benefit for population stability Environment Host provides optimal and stable conditions for life of microbiota, e.g. supply of nutrients, maintaining temperature and pH, keeping away perturbing foreign microorganisms Species richness Phenotypic variance insures microbial ecosystems against functional failure in accord to the insurance hypothesis: - buffering effect to respond to environmental perturbations - performance-enhancing effect Community formation More or less tight aggregations of microbial colonies, and formation of biofilms produce locally optimal conditions and protection: - „supergenome” in the population provides momentary adaptation to changes in the environment - coordinated population behaviour by quorum sensing Separation Life within the mucous layer along the epithelium and in spatial niches offers protection against competitors, mucous glycoproteins are utilised as food 26 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ microorganisms enmeshed within a matrix of extracellular polymeric substances. The matrix components are usually polysaccharides. Its formation is a pivotal strategy of bacterial survival in an inhospitable environment. That makes the affiliates in a way functionally similar to a multicellular organism. The matrix of the biofilm is produced by the cells constituting the biofilm, its structural integrity depends essentially on an intact bacterial metabolism (Il�ina et al. 2004, Branda et al. 2005). Planktonic bacteria when going to group together in a biofilm modify specific patterns of protein and gene expression, metabolic profile and specific physiology. They approach a new state that is termed «biofilm phenotype» (Whiteley et al. 2001, Sauer et al. 2002). Biofilm communities tend to be more resistant to antimicrobial stressors, involving those exerted by host-defence, than bacteria of the similar species living planktonic. That is apparently the manifestation of several factors including vitiated penetration of the antibiotic, metabolic activity and phenotypic variability of biofilm cells. Microbes growing in a colony may faster become antibiotic-resistant due to a greater opportunity of horizontal gene transfer. Such inducible competence and transformation mechanisms gave the basis of the «distributed genome hypothesis» or «supergenome hypothesis» (Ehrlich et al. 2005). It implies the following conceptions (Ehrlich et al. 2008): a huge phenotypic and genotypic diversity within a microbial species; an almost universally polyclonal microbial colonisation; and microbiomes in different hosts are considerably different. A microbial species is thus classified by a core genome that each member of a species possesses. It contains in addition distributed genes, which encompass genes that are not shared by all strains of a species. The species E. coli, for instance, possesses about 4000 obligate/core genes. In addition, there are about 2000 facultative genes, of which about 200-1500 genes are found in each individual strain. The assemblage of facultative genes codifies additional functions, which are not mandatory for survival. Rare metabolic routes, resistance against toxins, pathogenic or symbiosis features or speciation for colonisation of certain niches are such functions. Thus, the facultative genes are distributed in a gene pool. Optimised procedures of horizontal gene transfer afford immediate distribution among all members of the species. New strains can come up through inducible autocompetence and autotransformation systems. Contingency genes (hypermutable loci in the genome) are distributed 27 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà within the population and give the property of changes in phenotype at a frequency up to 1:100-1000 bacteria per generation. Typically, activities of genes are affected that interact with the environment. These mutations are random in time and cause heterogeneity within a population of replicating bacteria. That is an important mechanism of momentary adaptation to changes in the environment. Coordinated population behaviour to gain maximal benefit in a competitive environment implies intercellular communication. Bacteria send out and perceive «hormone-like» signal molecules that increase in concentration as a function of cell density («autoinducer»). The whole population initiates a concerted action as soon as the population density and the corresponding signal concentration approach a certain threshold. Few signal transmitting molecules have been identified: post- translationally modified peptides (Hardman et al. 1998), diketopiperazines furanosyl borate diester (Daniels at al. 2004), inorganic polyphosphates (Brown and Kornberg 2004), acetyl phosphate (Wolfe 2005), N-acylhomoserine lactones (Swift et al. 2001, Dong and Zang 2005). Target genes can synchronously be expressed among a local community and biological activities can be coordinated (Miller and Bassler 2001). This community genetic regulatory phenomenon was coined «quorum sensing». Evidence is provided that quorum-sensing signals influence cellular processes like biofilm association, responses to physicochemical stresses, organelle biogenesis, cell cycle regulation, phase variation in stationary-phase planktonic cultures, virulence factor expression, symbiosis, production of antibiotics, motility, swarming, sporulation, and conjugation. Bacteria embedded in a biofilm show considerable variability in metabolic and reproductive activity (Fux et al. 2005). The formation of the polymer matrix may increase or decrease in dependence on biofilm evolution (Nadell et al. 2008). Biofilms may contain bacteria of different species. A curious observation on the «social life» within a biofilm was reported recently (Diggle et al. 2007). These researchers showed exploitative behaviour of some individuals. Such bacteria avoid the expenditure of producing signal molecules and of partaking in cooperative activities, and thus proliferate faster than the kin relatives. Salmond et al. (1995) viewed the action of bacterial biofilms as an example of multi-cellularity in prokaryotic populations. The previous communications on the fascinating and diverse social life of bacteria will focus increasing attention into this field. 28 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ During the last decades a variety of factors that contribute obviously to the increased rate of infections by bacteria forming biofilms, e.g. excessive use of antibiotics, disturbances between intestinal flora and hosts immune system, failures in nutrition, damage of epithelia by intracorporeal medical devices with inappropriate coatings and improper application, failure of diagnostic procedures to recognise bacteria growing in a biofilm (Matsumoto and Takahashi 1994). Biofilms in water and its impact in human disease transmission were recently conferred by Huq et al. (2008). Kaufmann et al. (2008) considered the use of quorum-sensing blockers for therapeutic purposes. Studies with Pseudomonas aeruginosa show the role of quorum-sensing and neuraminidase-dependent biofilm formation for respiratory infection. Therefore, perturbance of quorum sensing by macrolides and inhibition of that enzyme may be a novel potential therapeutic perspective to prevent pneumonia (Otto 2004, Tateda et al. 2004, Raffa et al. 2005, Rice et al. 2005, Soong 2006). 4. Hosts immunity and microbiota Generally, each microbe when entering a human tissue may initiate ruinous outcomes for the host. Physical, chemical and immune barriers created by the intestinal epithelium and the adjacent lymphatic system protect the host against such unwelcome intrusion of enteric microorganisms. Four cell lineages, including enterocytes (form a thin layer of epithelial cells that separates the gut lumen from the mucosal immune system; support specific transport functions for nutrients and give information about the external milieu), hormone-producing entero- endocrine cells, goblet cells (mucin production), and Paneth cells (production of antimicrobial peptides and proteins), compose the epithelial barrier. Intercellular junctional protein complexes such as tight junctions, adherens junctions, and desmosomes maintain the integrity of the epithelium. In addition, M cells are specialised epithelial cells belonging to the follicle-associated epithelium that wraps Peyer�s patches. This cell type is involved in the communication between intraluminal microbiota and lymphatic tissue by sampling luminal antigens directly (see Fig. 1). Peyer�s patches, mesenteric lymph nodes, diffusely scattered lymphocytes, cryptopatches and great numbers of IgA producing plasma cells in the intestinal lamina propria and epithelium constitute the 29 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà GALT (gut-associated lymphoid tissue). It expands along the intestinal mucosa. One should remember that almost all components of the immune system are abundant at the end of a full-term pregnancy, but effective protection of the intestinal mucosa necessitates the microbial incitement of initial bacterial settling. It is customarily assumed that the immune system exclusively provides defence to the host against a multiplicity of bacterial threats from the environment. However, host immune system and the microbiota of its most adjacent environment establish a symbiotic, highly redundant network. It works as a two-way communication system and brings together the biodiversity of bacteria and the potentially multiple immune response of the host. In this network the host fulfils its keen rationale to keep under control the composition of the microbiota. Species- specific response to suppress or eliminate a particular microbial strain may be disabled, however, owing to the enormous strain diversity. Instead, mechanisms evolved to handle whole matching sets of bacteria with mutual structural and/or functional features. This mission has to be done for the most part by the innate immune system. It provides the first frontier of immune defence against infectious agents and on which the acquired immune system depends for activation and for the majority of its effector functions. To live together with numerous bacteria in our gut without any harmful effects is an outstanding feat by the local epithelium and the joining lymphoid tissue. The gut microflora, a great variety of antigens brought along with food, and potential pathogen germs continuously challenge the gastrointestinal defence. Intruded microbials were held off by a plethora of sensing and effector functions to initiate proper immune responses. Intact food antigens have to be excluded, an arrangement has to be made with commensals, and pathogens have to be abolished. That is an extremely intricate issue. Obviously a fine borderline secedes the homeostatic balance upheld in the presence of the commensal microbiota and the devastating response to invading bacterial pathogens. For this balance to maintain, a fine-tuned communication between microbiota, epithelium and the underlying lymphoid cells is mandatory. This enduring dialogue is coined microbial- epithelial crosstalk. It ensures tolerance to the normal bacterial flora and prevents inflammatory derailments and their detrimental clinical outcomes (Sansonetti 2004). 30 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Microbes present multifaceted surface structures that phagocytes should identify for immediate killing and triggering the expression of cytokines and chemokines that orchestrate host antimicrobial defence. The affiliated epithelium and the immune cells must first of all recognise present microbes, distinguish them from host cells, and discriminate pathogens from members of the indigenous microflora. Surface structures of microbes that both animals and insects are missing are the basis for this recognition. Janeway suggested this concept in 1989: «� the immune system has evolved specifically to recognize and respond to infectious microorganisms, and that this involves recognition not only of specific antigenic determinants, but also of certain characteristics or patterns common on infectious agents but absent from the host.» These structures were firstly coined PAMPs, for «pathogen- associated molecular patterns». Since such structures are also present in most non-pathogenic species, the term «microbe-associated molecular patterns» MAMPs should be preferred. The recognising molecules on host cells are termed pattern recognition receptors (PRR). In the Table 6 are surveyed PRRs, the corresponding ligands, and the microbes to be recognised by this system as gleaned in the last one decade. PRR are protein molecules located in outer and inner cell membranes and in the cytoplasm of immune cells and cells of other tissues. A collection of soluble pattern recognising molecules, mainly but not exclusively produced by the liver, circulates in body fluids and contributes to opsonification and complement activation. Recognition is dependent on receptor-ligand interaction between pattern recognising protein molecules on host cells and MAMPs of the microorganism (Medzhitov and Janeway Jr. 1997). Toll-like receptors (TLR), the ß-glucan-receptor Dectin 1 and the mannan receptor on the outer cell membrane and the soluble intracellular proteins NOD1 and NOD2 appertain to cell- associated PRR. They are germ-line encoded and predominantly expressed on macrophages/monocytes, neutrophils, fibroblasts, B cells, dendritic cells, mucosa epithelium cells, endothelial cells, and regulatory T cells (Treg). Thirteen TLRs have been found in mammals as yet. Although the recognition mechanism at the molecular level is well studied, the mechanisms of discrimination and confining potentially harmful bacteria and allowing indigenous microbiota to remain are far from being elucidated. That is even more amazing, since the cells make use of mutual molecular signalling routes. PRRs bound to membranes 31 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà such as TLRs act as signal-transducer. Binding of the particular MAMP on the extracellular portion of the corresponding PRR that bears a motif of leucine-rich repeats initiates dimerisation and/or complexation with other receptor molecules on the inside of the cell membrane. A set of adaptor proteins is recruited to amplify the down-stream signalling. The reaction cascade discharges into activation of transcription factors (NF-êB, Activator protein1), which enter the cell nucleus and lead to a distinct array of gene expression products (Fig. 2). These gene products (cytokines, interleukins) arrange innate immune responses and direct development of antigen-specific acquired immunity (Medzhitov and Janeway 1997, Hallman et al. 2001, Akira and Takeda (2004), Oda and Kitano (2006), deFRanco et al. 2007, Krishnan et al. 2007). In this framework MyD88 acts as the primary adaptor for microbial signalling and NF-êB is accepted as the central mediator of the immune response. Specificity of signalling is approached by collaboration among TLRs and of TLRs with other receptors, differential utilisation of adaptor proteins, collaboration among multi-transcription factor binding sites in the promoter region of a certain gene, interaction with TLR-independent signalling routes, and so on. Negative and positive feedback loops preclude rampant inflammation that gives rise to ample tissue damage and fatal clinical outcomes. In addition to an appropriate response to a pathogen TLRs play a role in immune cell differentiation and maturation. Since TLRs are able to recognise endogenous molecules of the host (e.g. heat shock proteins, fibronectin, RNA, ATP) a function of these PRR may be anticipated in restraint of immune disorders. Abbreviations used in the Table 6. Components of antimicrobial defence Abbreviations S = skin E = eye (tear) O = oral cavity G = stomach R = respiratory tract F = female genital tract U = urinary tract LPS = lipopolysaccharide SLPI = Secretory leukocyte proteinase inhibitor SPLA2 = Secretory phospholipase A2 32 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Figure 2. Bow-tie architecture of microbiota-human symbios. 33 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà T ab le 6 � N on -c el lu la r co m po ne nt s of a nt im ic ro bi al d ef en ce C om po ne nt S E O G I R F U T ar ge t o f a nt im ic ro bi al a nd p ro te ct iv e ac tiv iti es P ep tid e, P ro te in A ni o n ic p e p tid e + E . co li, S ta p h. a ur e us , P s. a e ru g. , K . p ne u m o ni a e B P I + + + G ra m -n e ga tiv e sp ec ie s, n e ut ra lis es L P S C at he lic in + + + + + S yn er gi c ac tiv ity w ith ly so zy m e a ga in st m a n y b ac te ria , ne ut ra lis e s LP S , a ttr a ct s ne ut ro p hi ls , m o no cy te s a nd T - ly m p ho cy te s (C D 4 ) C o e ru lo p la sm in + B in d in g o f c op p e r C o lle ct in s + S ur fa ct an t pr ot ei ns ; K le bs ie lla p ne u m o ni ae C o m p le m e n t + M ic ro b ia l l ys is a nd o p so ni sa tio n, α- D e fe ns in -5 + + C a nd . a lb ic a n s, E . c o li, S ta p h. a ur e u s, L is . m o no cy to ge ne s, B a c. c e re us ß -D e fe ns in -1 + + + + + + + + G ra m -p o s. /n e g. s p e ci e s, C a nd . a lb ic a ns ß -D e fe ns in -4 + + + E . co li, S ta p h. a ur e us , P s. a e ru g in o sa , K . p ne u m o ni a e , at tr ac ts m o no cy te s C a lp ro te ct in + + E . co li, S ta p h. a ur e us , K le b si e lla , C a nd . a lb . D e rm ci d in + E . co li, S ta p h. a ur e us , C a nd . a lb ., E nt . f a e ca lis E la fin + + + S ta p h. a ur e us , P s. a e ru gi no sa , ne ut ra lis e s LP S , in hi b its ne ut ro p hi l e la st a se F ib ro ne ct in + F ac ili ta te s p ha go cy to si s G la nd ul in + G ra m -n e g. s pe ci e s H e m o ci d in s + E . co li, S al m o ne lla , E n t. fa ea lis H e p ci d in + + C a nd id a a lb ic a n s, E . co li, S ta p h. e p id er m id is H is ta tin s + Y e a st s, s up pr e ss io n o f c yt o ki ne in d uc tio n a nd p la q ue fo rm at io n, a ttr ac ts m o no cy te s 34 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ C om pi le d fr om B ei ss w en ge r an d B al s 20 05 , L ié vi n -L e M oa l an d S er vi n ( 20 06 ), M cA ul ey e t al . 20 07 , W il so n 2 00 8. C om po ne nt S E O G I R F U T ar ge t o f a nt im ic ro bi al a nd p ro te ct iv e ac tiv iti es Ig A , Ig M + P re ve nt m ic ro b ia l a d he si o n, a ci va te c o m p le m e nt , La ct o fe rr in + + + + + F e -b in d in g, a ct iv a te s N K c e lls , S tr e p . m u ta n s, E . co li, V ib ri o ch o le ra e, B ac . su b til is La ct o p e ro xi d a se + + + + R e d o x ca ta ly st , S ta p h. a ur e u s, s tr e p to co cc i, H . in flu e nz a e , E . co li, P re vo te lla , P se ud o m o n a s L ys o zy m e + + + + + + P ro d uc e d b y st a p h yl o co cc i, a gg lu tin a te s G ra m -p o s. b a ct e ri a M uc in -7 + N -t e rm in a l c le a ve d p e p tid e s a nt im ic ro b ia l a ct iv e P so ri a si n + E . co li, c he m o ki ne s R e g II Iy + Li st . m o no cy to ge ne s a nd in no cu a , E n t. fa e ca lis S ia lin + B in d s m ic ro b e s S LP I + + + + + + E .c o li, P s. a e ru gi n. , S ta p h. a ur e us , in h ib its L P S S P LA 2 + + + G ra m -p o si tiv e sp ec ie s S ta th e ri n + + P se ud o m o na s a e ru gi no sa T ra ns fe rr in + F e -b in d in g O th er A ci d p H + + + A ci d s p ro d uc e d b y ho st ( G ) o r B a ct e ri a ( S ,F ) B ile a ci d s + P re do m in a nt ly G ra m -p o si tiv e s p e ci e s C O 2 + P ro d uc e d b y b a ct e ri a , in hi b its d e rm a to p h yt e s S he d d in g + + + + + + S he d c e lls c a rr y m ic ro b e s F lo w + + + + M ic ro b e s d is p la ce d fr o m s ur fa ce s 35 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà This complex immune system and the coexistence with the microbiota pose numerous questions, such as: Why there is no permanent inflammation on the mucosal/epithelial surfaces («commensal paradox»)? There are counteracting mechanisms that bolster or hinder microbial diversity: Why in vertebrates the microbial diversity is greater than in invertebrates, although vertebrates possess a stronger immune system, which may damp diversity? What consequences have bacterial life and sympatry in micro-niches, resource competition, promoted gene flow through random mating, and competitive exclusion on species diversity? How robustness, fragility, resource limitation and performance are involved in the symbiotic association of microbiota and hosts immunity? What are the consequences of systemic or local disturbances? Did the vertebrate immune system evolve under selection pressure to maintain a diverse and stable microbiota? Systems biological methodology gains in importance to disentangle the possible logic behind the network and is beginning to answer such questions (Csete and Doyle 2004, Seymour 2005, Kitano and Oda 2006, Kitano 2007). In Seymour�s model the host possesses a number of distinct niches, which harbour generalist and specialist species with varying rates of growth and reproduction. A low rate of mutation between closely related species and some migration along routes linking niches are permitted. The host acts like a predator in an ecological community, but one with adaptable prey preferences, and uses its immune system to retard the growth rate of the microbiota. The diversity between niches increases with the strength of immunity. In the absence of systematic disturbance a reasonable strong immune response yields highly diverse communities dominated by several distinct species of specialists. Stochastic disturbances such as transitory compromises of immune response constrained diversity of microbiota. Disturbances having a preference to niches yield competitive dominance by the generalist members. Seymour supposes that the high diversity with the relatively even abundance of most species could be related with the commensal paradox: inflammation demands «above threshold» signals to trigger the local cytokine network. A number of investigators attempted to unveil the design principle and the structural topology of biological networks in relation to their function by use of mathematical models and computer simulation. For it, complex biological networks were deconstructed into conceptually 36 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ simple entities (modules) that are made up of many species of interacting molecules (Hartwell et al. 1999, Papin et al. 2004). These networks have topologies that are principally different to those in simple randomly linked networks. The choice of bow-tie as a structural building unit proved to be a concise and smart option for constructing metabolic and signal transduction networks (Zhao et al. 2006, Kitano 2007). One of the fundamental characteristics of biological systems is robustness. It is a «property that allows a system to maintain its function against internal and external perturbations» (Kitano and Oda 2006, Oda and Kitano 2006). Kitano and co-workers propose that the intracellular signal transduction pathways and the intercellular signal processes of both the innate and acquired immune system consist of a modularised tandem bow-tie pattern (Fig. 2). The MyD88-adapter- protein complex and NF-êB act as bottlenecks in this topology. This main bow-tie network has extensive collateral pathways with multiple positive/negative system controls and crosstalk regulations that may modulate downstream performance. Such an architecture is characterised by a great «fan-in» of signals recognised by PRR, and a great «fan- out» of cytokines, chemokines, and interleukins. In the consequence, the response of the signalling network to a specific set of stimuli depends on the activation levels and temporal dynamics of molecules in this theoretical hyperspace. That modularised bow-tie design leads to inherent trade-offs among robustness, fragility, resource limitation, and performance. A modular signalling network that is nested by many relatively independent and robust bow-tie units, will give more advantages in generating coordinated response to various stimuli from environment. Both symbiotic partners � host�s immune system and a diverse microbiota � coevolved in a symbiotic relationship to optimise robustness against pathogen challenges and nutrient perturbations. This concept is in harmony with «conclusions from a number of studies that these structures result from universal and fundamental organising principles for efficiency and robustness, rather than frozen accidents of evolution» (Zhao et al. 2006). There is a further point of benefit for the host: the enduring homeostasis of microbiota might be exceptionally important against autoimmune disorders and other immune derailments which are predicated on the intrinsic tendency of the immune system toward hyperactivity. 37 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà 5. How to improve a tilted host-microbiota partnership? Factors accompanying our current life such as over- and malnutrition, physical inactivity, excessive use of tobacco, alcohol, drugs and medicine, UV-irradiation, incorporation/inhalation of pesticides, toxic gases and heavy metals and growing-up in a sanitised world disturb the immune balance and the host-microbiota partnership with the consequence of a huge increase of chronic inflammatory diseases, e.g. atherosclerosis, inflammatory bowel diseases, diabetes, asthma, rheumatism, neurodermatitis, psoriasis, adipositas, and cancer. The anticipation to improve the host-microbiota partnership, immunity and constitutional performance by food additives is based on four aspects: i) using the recent advance in understanding of the dynamic interplay between host immune system and microbiota, ii) recognising the established history of using health-promoting extracts of fungi, algae and herbs in traditional oriental medicine and in food supplementation, iii) assuring usefulness and safety of food ingredients for disease prevention and treatment, and iv) the bioactive molecules to come into question can be given to the diet, without the prerequisite to cope with phase-I/II/III clinical trials. Orally administered agent�s come into direct contact with the largest immune tissue GALT and its microenvironment in the intestine, which may have an explicit effect on the microbiota and the ensuing final immune response. There may be three options to accomplish such an entitlement: i. Immunomodulating option: Uptake of immune modulating ingredients to prevent inflammatory lapse or trace back a derailed immune system into balance. ii. Prebiotic option: Uptake of non-digestible substrates to feed health-promoting members of indigenous microbiota, e.g. Bifidus spp. iii. Probiotic option: Uptake of health-promoting bacteria such as Lactobacillus spp. and Bifidus spp. Compounds that can interact with the immune system to upregulate or downregulate the host response are termed immunomodulator, or synonymously immunostimulant, immunopotentiator, immune enhancer, or biological response modifier. The concept of immunomodulation is to induce the same response as that taking place during the initial phase in a common infection without producing sustained dangerous inflammation or harsh side-effects. A particular immune sub-function 38 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ has to be increased or suppressed in such a way as to enhance or complement a desired response. Such a proceeding is promising since i) it strengthens hosts own defence mechanisms, and ii) it excludes the use of species-specific antibiotics. The inflammatory reaction mostly attains a fine balance that eliminates pathogen microbes and repairs damaged tissues. Strictly regional low-grade inflammations may occur now and then and should be understood as a sub-clinical everyday occurrence. However, the fine- tuned response can go awry and a persistent inflammation arises, often lacking a recognisable infection. Cytokines, interleukins and chemokines are local messenger molecules that mediate information between cells. These mediators have a great impact on cell division, differentiation, growth and immunity. It makes sense to envisage the cytokines as constituting a network of inherent agonist and antagonist functions, e.g. pro-inflammatory and anti-inflammatory reactivity, or growth-promotion and suppression (Balkwill 2000). At an inflammatory site pro- as well as anti-inflammatory mediators are consecutively up-regulated followed by down-regulation. In states of chronic inflammation the equilibrium is skewed towards the inflammatory arm. The outbalanced cytokine network induces inflammatory cell recruitment of the tissue(s) concerned, vitiation of cell functions, and tissue-matrix injury. Many immunomodulating compounds are polysaccharides or polysaccharide-protein complexes, such as the zwitterionic polysaccharides, mannans, protein bound polysaccharides PSK and PSP, and hyaluronan. One of the best studied is the group of beta-glucans. These polysaccharides are widely distributed in the biological matter in, for example, yeast, fungi (excluding zygomycetes), bacteria, and lower and higher plants. They occur as a primary constituent in the cell wall of fungi and bacteria. (1→3)-beta-glycosidic bonds link the glucose units in the backbone. Side chains are formed as (1→4)-linkages or as (1→6)- linkages. (1→3),(1→6)-beta-D-Glucans are non-toxic, non-immunogenic, and non-allergenic. beta-Glucans react with PRRs (e.g. Dectin1) on monocyte/macrophages, natural killer cells, neutrophils, dendritic cells, vascular endothelial cells, keratinocytes and fibroblasts. The macrophage has been identified as the master cell in the first line of defence against most infections as well as in mediating the response of the innate and acquired immunity. This cell type can be activated as the result of a common infection process or by products of fungi or bacteria. 39 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Binding of beta-glucan to macrophages initiates complexation of the beta-glucan receptor with TLR2 and TLR6 and activation of signal transduction pathways involving NF-êB-like transcription factors (Luhm et al. 2006). It alerts the innate immune system and primes it to respond immediately and properly to infections. The anti-inflammatory efficacy has been shown in-vitro and in-vivo (Gerber et al. 2005, Lull et al. 2005, Dillon et al. 2006, Jung et al. 2007). As an example, the Figure 3 shows the results of a study on thoroughbred race-horses performed in springtime. In that period regular hair coat replacement, environmental changes, intensification of training loads, transportation, heavy physical exertion and competitive races, and frequent contacts to other animals bring about an enduring metabolic, immune and psychological stress. The animals respond with elevation of acute phase proteins in blood (fibrinogen, haptoglobin, SAA), which are accepted markers of inflammation. These changes are ameliorated by the immune modulating activity of yeast beta-glucan. In 1995 Gibson and Roberfroid inaugurated the prebiotic concept as part of the functional food strategy. A prebiotic should fulfil the following criteria: inertness against hydrolytic cleavage and absorption in the upper part of the gut, acting as selective substrate for one or few health-promoting colonic bacterial species, and constraining pathogens via keeping up growth and/or activity of health-promoting species. Gibson et al. (2004) suggested a definition of prebiotics taking into account nutritional, biochemical, physiological and microbial areas that may benefit from a selective targeting of particular micro-organisms: «A prebiotic is a selectively fermented ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microflora that confers benefits upon host well-being and health». At present the only compounds with prebiotic functions are carbohydrates. The genera commonly targeted are Bifidobacterium and Lactobacillus, the growth and activity of which should be increased. Human breast milk may be seen as the prebiotic per se. The bifidus factor � a glycoprotein � is the specific entity responsible for the dominance of bifidus bacteria in the colon of newborns fed breast milk. A range of oligosaccharides has been proven in experimental studies to exert prebiotic activity, e.g. oligosaccharides of fructose, galactose, mannose, xylose, and (1→6)-linked glucose, lactulose, isomaltoo- ligosaccharide, palatinose, and tagatose. However, in food manufacturing 40 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ around the globe inulin, fructooligosaccharides, and galacto- oligosaccharides are the dominating types. There are attempts to develop a «second generation» of prebiotics with enhanced activity and desirable attributes such as fine control of microflora modulation, specific inhibition of pathogen adhesion, varying viscosity, lack of side- effects, and persistence to distal regions of the colon (Rastall and Gibson 2002). The term «probiotic» was coined by Lilly and Stillwell (1965) in contrast to antibiotic to describe substances secreted by one microorganism, which stimulates the growth of another. Following Havenaar and Huis In´t Veld (1992) and Schrezenmeir and de Vrese M (2001) a probiotic is defined as «A preparation of or a product containing viable, defined microorganisms in sufficient numbers, which alter the microflora (by implantation or colonization) in a compartment of the host and by that exert beneficial health effects in this host». This definition is applicable independent of the probiotic site of action and the route of administration. A synbiotic � in the strongest sense of the term � is a blend of a prebiotic and a probiotic «� in which Figure 3: Yeast (1?3),(1?6)-beta-D-glucan (Vitagard P) attenuates the springtime stress-associated increase of the acute phase protein fibrinogen in blood serum of race-horses. 41 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà the prebiotic compound selectively favours the probiotic compound» (Schrezenmeir and de Vrese M, 2001). The beneficial effects of probiotics and prebiotics on human health are critically surveyed by Hanske and Blaut (2006). The probiotics aimed for human use must fulfil a number of criteria: preferentially from human origin, genetically stable, non-pathogenic and safe, insensitive to gastric acidity and bile salt, and to remain viable during technological processing. The comprehension of the mechanisms underlying the health promoting claim(s) should be verified by a scientifically established methodology to improve the credibility of the prebiotic and probiotic conception. Utilisation of advanced molecular methods for monitoring variations in the particular microbiota are compulsory. References Achtman M, Wagner M (2008) Microbial diversity and the genetic nature of microbial species. Nature Rev. Microbiol. 6:431-440. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499—511. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104:979-984. Balkwill F (Ed.) (2000) The Cytokine Network. Oxford University Press, Oxford, UK. Beisswenger C, Bals R (2005) Functions of antimicrobial peptides in host defense and immunity. Curr. Protein Pept. Sci. 6:255-264. Branda SS, Vik S, Friedman L, Kolter R (2005) Biofilms: the matrix revisited. Trends Microbiol. 13:20-26. Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize L, Maisch S, Carr D, Gerlach F, Bufe A, Lauener RP, Schierl R, Renz H, Mutius E von, Allergy and Endotoxin Study Ream (2002) Environmental exposure to endotoxin and its relation to asthma in school-age children. New Engl. J. Med. 347:869-877. Braunstein J, Qiao L, Autschbach F, Schürmann G, Meuer S (1997) T cells of the human intestinal lamina propria are high producers of interleukin-10. Gut 41:215-220. Brown, MR, Kornberg A (2004) Inorganic polyphosphate in the origin and survival of species. Proc. Natl. Acad. Sci. U S A. 101:16085-16087. Cash HL, Whitham CV, Behrendt CL, Hooper LV (2006) Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126-1130. Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7:178-182. 42 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Cole D, Todd L, Wing S (2000) Concentrated swine feeding operations and public health: A review of occupational and community health effects. Environm. Health Perspect. 108:685-699. Cossart P, Boquet P, Normark S. Rappuoli R (1996) Cellular microbiology emerging. Science 271:315-316. Costabile A, Klinder A, Fava F, Napolitano A, Fogliano V, Lenard C, Gibson GR, Tuohy KM (2008) Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Brit. J. Nutr. 99:110-120. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM (1995) Microbial biofilms. Annual Rev. Microbiol. 49:711-745. Csete M, Doyle J (2004) Bow ties, metabolism and disease. Trends Biotechnol. 22:446-450. Daniels R, Vanderleyden, Michiels J (2004) Quorum sensing and swarming migration in bacteria. FEMS Microbiol. Rev. 28:261-289. Darwin C. (1859) On the Origin of Species by Means of Natural Selection. J. Murray. London. De Backer E, Verhelst R, Verstraelen H, Alqumber MA, Burton JP, Tagg JR, Temmerman M, Vaneechoutte M (2007) Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Biol. 7:115. Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature.449(7164):811-818. deFranco AL, Locksley RM, Robertson M (2007) Immunity: The Immune Response in Infectious and Inflammatory Disease. New Science Press Ltd., London, UK. Diggle SP, Griffin AS, Campbell GS, West SA (2007) Cooperation and conflict in quorum-sensing bacterial populations. Nature 450(7168):411-414. Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter K, Kaspro- wicz DJ, Kellar K, Pare J, van Dyke T, Ziegler S, Unutmaz D, Pulendran B (2006) Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116:916-928. Dong YH, Zhang LH (2005) Quorum sensing and quorum-quenching enzymes. J. Microbiol. 43 Spec. No:101-109. Doolittle RF, Feng DF, Tsang S, Cho G, Little E (1996) Determining divergence times of the major kingdoms of living organisms with a protein clock. Science 271(5248):470-477. Duddington CL (1961) Micro-Organisms as Allies. Faber and Faber, London, UK. Dunny GM, Winans SC (Eds.) (1999) Cell Signalling in Bacteria. Am. Soc. Microbiol. Press, Washington D.C., USA. 43 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635-1638. Ehrlich GD, Hu FZ, Shen K, Stoodley P, Post JC (2005) Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin. Orthop. Rel. Res. 437:20-24. Ehrlich GD, Hiller NL, Hu FZ (2008) What makes pathogens pathogenic. Genome Biol. 9:225. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM et al. (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512. Fuqua WC, Winans SC, Greenberg EP (1994) Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 176:269—275. Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40. Gandara A, Mota LC, Flores C, Perez HR, Green CF, Gibbs SG (2006) Isolation of Staphylococcus aureus and antibiotic-resistant Staphylococcus aureus from residential indoor bioaerosols. Environm. Health Perspect. 114:1859-1864. Gao Z, Tseng C-H, Pei Z, Blaser M (2007) Molecular analysis of human forearm superficial skin bacterial biota. Proc. Natl. Acad. Sci. USA 104:2927-2932. Gerber G, Fleischer L-G, Lippert E, Westphal G (2005) (1?3),(1?6)-beta-D-glucan: Effects on blood parameters and performance of chickens. In: Vitamine und Zusatzstoffe in der Ernährung von Mensch und Tier. 10. Symposium, 28.-29. September 2005, Jena/ Thüringen (Schubert R, Flachowsky G, Jahreis G, Bitsch R, Hrsg). pp 144—151. FSU Jena und FAL Braunschweig, Germany. Gibbons RJ, Fitzgeraldd RJ (1969) Dextran-induced agglutination of Streptococcus mutans, and its potential role in the formation of microbial dental plaques. J. Bacteriol. 98:341-346. Gibbs SG, Green CF, Tarwater PM, Mota LC, Mena KD, Scarpino PV (2006) Isolation of antibiotic resistant bacteria from the air plume downwind of a swine confined or concentrated animal feeding operation. Environm. Health Perspect. 114:1032-1037. Gibson GR, Probert HM, Loo J, Rastall RA, Roberfroid MB (2004): Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17:259-275. Gibson G, Roberfroid MBR (1995): Dietary modulation of the human colonic microbiota — introducing the concept of prebiotics. J. Nutr. 125:1401—1412. Gorak EJ, Yamada SM, Brown JD (1999) Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin. Infect. Dis. 29:797-800. 44 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Gordon JI, Hooper LV, McNvin MS, Wong M, Bry L. (1997) Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT. Am. J. Physiol. 273:G565-G570. Guggenheim B, Schroeder HE (1967) Biochemical and morphological aspects of extracellular polysaccharides produced by cariogenic streptococci. Helv. Odont. Acta 11:131-152. Gutzeit E (1918) Die Bakterien im Hauhalt der Natur und des Menschen. 2. Aufl., Verlag Teubner, Leipzig und Berlin, Germany. Hallman M, Rämet M, Ezekowitz RA (2001) Toll-like receptors as sensors of pathogens. Pediatr. Res. 50:315-321. Hamscher G, Pawelzick HT, Sczesny S, Nau H, Hartung J (2003) Antibiotics in dust originating from pig-fattening farm: a new source of health hazard for farmers. Environm. Health Perspect. 111:1590-1594 Handelsman J, Robinson CJ, Raffa KF (2005) Microbial communities in lepidopteran guts: From models to metagenomics. In: The Influence of Cooperative Bacteria on Animal Host Biology (McFall-Ngai MJ, Henderson B, Ruby E., eds.) Adv. Mol. Cell. Microbiol. 10:143-168. Hanske L, Blaut M (2006) Mechanisms underlying the effects of probiotics. Akt. Ernähr. Med. 31:317-321. Hardman AM, Stewart GS, Williams P (1998) Quorum sensing and the cell-cell communication dependent regulation of gene expression in pathogenic and non-pathogenic bacteria. Antonie Van Leeuwenhoek. 74:199-210. Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999) From molecular to modular cell biology. Nature 402(6761 Suppl):C47-C52. Hausmann M, Kiessling S, Mestermann S, Webb G, Spöttl T, Andus T, Schölmerich J, Herfarth H, Ray K, Falk W, Rogler G (2002) Toll-like receptors 2 and 4 are up- regulated during intestinal inflammation. Gastroenterol. 122:1987-2000. Havenaar R, Huis in´t Veld J (1992) Probiotics: a General view: In: The Lactic Acid Bacteria. Vol. I: The Lactic Acid Bacteria in Health and Disease. Wood EJB (ed.) Elsevier Applied Science, pp151-170. Heederik D, Sigsgard T, Thorne PS, Kline JN, Avery R, Bønløkke JH, Chrischilles EA, Dosman JA, Duchaine C, Kirkhorn SR, Kulhankova K, Merchant JA (2007) Health effects of airborne exposures from concentrated animal feeding operations. Environm. Health Perspect. 115:298-302. Henderson B, Wilson M, McNab R, Lax AJ (1999) Cellular Microbiology: Bacterial-Host Interactions in Health and Disease. John Wiley & Sons, Chicester, UK. Heywood, V.H. (ed.). 1995. Global Biodiversity Assessment. United Nations Environment Programme. Cambridge University Press, Cambridge, USA. 45 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P, O´Gorman B, Jarnicki A, McGuirk P, Mills KH (2003) Toll-like receptor 4-mediated innate IL- 10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171:3119-3127. Hickman CS (2005) How bacteria contributed to the evolution of multicellular animals. In: The Influence of Cooperative Bacteria on Animal Host Biology. Adv. Mol. Cell. Microbiol. 10:3-33. Huq A, Whitehouse CA, Grim CJ, Alam M, Colwell RR (2008) Biofilms in water, its role and impact in human disease transmission. Curr. Opinion Biotechnol. In press. Huttunen K, Hyvärinen A, Nevalainen A, Komulainen H, Hirvonen M-R (2003) Production of proinflammatory mediators by indoor air bacteria and fungal spores in mouse and human cell lines. Environm. Health Perspect. 111:85-92. Il’ina, T. S., Romanova. Iu. M., Gintsburg, A. L. (2004) Biofilms as a mode of existence of bacteria in external environment and host body: the phenomenon, genetic control, and regulation systems of development. Genetika. 40:1445-1456 (Russian). Jin MS, Lee JO (2008) Structures of TLR-ligand complexes. Curr. Opin. Immunol. [Epub ahead of print]. Jung KH, Kim MJ, Ha E, Kim HK, Kim YO, Kang SA, Chung JH, Yim SV (2007) The suppressive effect of beta-glucan on the production of tumor necrosis factor-alpha in BV2 microglial cells. Biosci. Biotechnol. Biochem. 71:1360-1364. Kaufmann GF, Park J, Janda KD (2008) Bacterial quorum sensing: a new target for anti-infective immunotherapy. Expert. Opin. Biol. Ther. 8:719-724. Kitano H, Oda K (2006) Robustness trade-offs and host microbial symbiosis in the immune system. Mol. Systems Biol. doi:10.1038//msb4100039. Kitano H (2007) Towards a theory of biological robustness. Mol. Systems Biol. 3 doi:10.1038//msb4100179. Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, Choi S (2007) Toll-like receptor signal transduction. Exp. Mol. Med. 39:421-438. Lewkowicz P, Lewkowicz N, Sasiak A, Tchórzewski H (2006) Lipopolysaccharide- activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 177:7155-7163. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102:11070-11075. Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-848. Liévin-Le Moal V, Servin AL (2006) The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 19:315-337. Lilly DM, Stillwell RH (1965) Probiotics: Growth-promoting factors produced by microorganisms. Science 147:747-748. 46 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Luhm J, Langenkamp U, Hensel J, Frohn C, Brand JM, Hennig H, Rink L, Koritke P, Wittkopf N, Williams DL, Mueller A (2006) Beta-(1g3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio. BMC Immunol. 7:5. Lull C, Wichers HJ, Savelkoul HF (2005) Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm. 2005(2):63-80. Doi: 10.1155/ MI.2005.63 Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA (2004) Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect. Immun. 72:6446-6454. Matsumoto T, Takahashi K (1994) Physiologic factor in intractable bacterial infections Nippon Rinsho. 52:315-321. (Article in Japanese). Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107-118. Mazmanian SK, Kasper DL (2006) The love-hate relationship between bacterial polysaccharides and the host immune system. Nature Rev. Immunol. 6:849-858. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA (2007) MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J. Clin. Invest. 117:2313-2324. McFall-Ngai M (2005) The interface of microbiology and immunology: a comparative analysis of the animal kingdom. In: The Influence of Cooperative Bacteria on Animal Host Biology. Adv. Mol. Cell. Microbiol. 10:35-56. McVean G, Spencer CC, Chaix R (2005) Perspectives on human genetic variation from the HapMap Project. PLoS Genet. 1(4):e54. Medzhitov R, Janeway CA Jr. (1997) Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298. Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT (2003) Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170:1406-1415. Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annu. Rev. Microbiol. 165-199. Moore WE, Holdeman LV (1974) Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl. Microbiol. 27:961-979. Moreau MC, Raibaud P, Muller MC (1982) Relationship between the development of the intestinal IgA immune system and the establishment of microbial flora in the digestive tract of young holoxenic mice. Ann. Immunol. (Paris). 133:29-39 (in French). 47 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Nadell CD, Xavier JB, Levin SA, Foster KR (2008) The evolution of quorum sensing in bacterial biofilms. PLoS 6(1):e14. Nanthakumar NN, Dai D, Newburg DS, Walker WA (2003) The role of indigenous microflora in the development of murine intestinal fucosyl- and sialyltransferases. FASEB J. 17:44-46. Norberg J, Swaney DP, Dushoff J, Lin J, Casagrandi R, Levin SA (2001) Phenotypic diversity and ecosystem functioning in changing environments: A theoretical framework. Proc. Natl. Acad. Sci USA 98:11376-11381. Oda K, Kitano H (2006) A comprehensive map of the toll-like receptor signaling network. Mol. Syst. Biol. 2. doi: 10.1038/msb4100057. Otto M (2004) Quorum-sensing control in Staphylococci — a target for antimicrobial drug therapy. FEMS Microbiol. Lett. 34:577-588. Palmer J, Flint S, Brooks J (2007) Bacterial cell attachment, the beginning of a biofilm. J. Ind. Microbiol. Biotechnol. 34:577-588. Papin JA, Reed JL, Palsson BO (2004) Hierarchical thinking in network biology: the unbiased modularization of biochemical networks. Trends Biochem. Sci. 29:641-647. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE (2001) Bacterial diversity in human subgingival plaque. J. Bacteriol. 183:3770-3783. Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ (2004) Bacterial biota in the human distal esophagus. Proc. Natl. Acad. Sci. USA 101:4250-4255. Platz S, Scherer M, Unshelm J (1995)Untersuchungen zur Belastung von Mastschweinen sowie der Umgebung von Mastschweineställen durch atembaren Feinstaub, stallspezifische Bakterien und Ammoniak. Zentralbl. Hyg. Umweltmed. 196:399-415. Probert HM, Gibson GR (2002) Bacterial biofilms in the human gastrointestinal tract. Curr. Issues Intest. Microbiol. 3:23-27. Raffa RB, Iannuzzo JR, Levine DR, Saeid KK, Schwartz RC, Sucic NT, Terleckyj OD, Young JM (2005) Bacterial communication («quorum sensing») via ligands and receptors: a novel pharmacologic target for the design of antibiotic drugs. J. Pharmacol. Exp. Ther. 312:417-423. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229-241. Rappuoli R (2006) Shaping of the bacterial world by human intervention. In: The Influence of Cooperative Bacteria on Animal Host Biology. Adv. Mol. Cell. Microbiol. 10:399-408. Rastall RA, Gibson GR (2002): Prebiotic oligosaccharides: Evaluation of biological activities and potential future developments. In: Probiotics and Prebiotics: Where Are We Going? pp107—148. Tannock G. W. (ed.), Caister Academic Press. Wymondham/Norfolk, UK. 48 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Reid G. (2004) When microbe meets human. Clin. Infect. Dis. 39:827-830. Rice SA, McDougald D, Kumar N, Kjelleberg S (2005) The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections. Curr. Opin. Invest. Drugs 6:178-184. Rieger MA (2001) Biologische Belastungen der Beschäftigten in der Landwirtschaft. Thesis Bergische Universität Gesamthochschule Wuppertal, Germany. Rosenberg E (2005) Coral symbiosis: The best and worst of three kingdoms. In: The Influence of Cooperative Bacteria on Animal Host Biology. Adv. Mol. Cell. Microbiol. 10:103-118. Rowe-Magnus D, Mazel D (2006) The evolution of antibiotic resistance. In: Evolution of Microbial Pathogens. (Seifert HS, DiRita VJ; eds.) pp 221-241. ASM Press, Washington DC, USA. Roy CJ, Milton DK (2004) Airborne transmission of communicable infection — the elusive pathway. New Engl. J. Med. 350:1710-1712. Salmond GP, Bycroft BW, Stewart GS, Williams P (1995) The bacterial «enigma»: cracking the code of cell-cell communication. Mol. Microbiol. 16:615-624. Sansonetti PJ (2004) War and peace at mucosal surfaces. Nat. Rev. Immunol. 4:953-964. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 184:1140-1154. Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 31:107-133. Schell MA, Karmiantzou M, Snel P, Vilanova D, Berger B, Pessi G, Zwahlen MC, Desiere F, Bork P, Delley M, Pridmore RD, Arigoni F (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. USA 99:14422-14427. Schrezenmeir J, de Vrese M (2001) Probiotics, prebiotics, and synbiotics — approaching a definition. Am. J. Clin. Nutr. 73(Suppl 2):361S-364S. Seymour RM (2005) Commensal diversity and the immune system: Modelling the host- as-network. In: The Influence of Cooperative Bacteria on Animal Host Biology. McFall-Ngai MJ, Henderson B, Ruby EG. eds.). Cambridge University Press, Cambridge, USA. Singleton P. (1997) Bacteria in Biology, Biotechnology and Medicine. 4th ed., John Wiley & Sons Ltd., Chicester, UK. Skerman VBD, McGowan V, Sneath PHA (Eds.) (1989) Approved Lists of Bacterial names. Washington (DC) Am. Soc. Microbiol., USA. Smith RD, Coast J (2002) Antimicrobial resistance: a global response. Bull. WHO 80:126-133. 49 ÏðåðîìàíòèçìÐîçä³ë 1. Åêîëîã³÷íà áåçïåêà Sonnenburg JL, Angenent LT, Gordon JI (2004) Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nature Immunol. 5:569-573. Soong G, Muir A, Gomez MI, Waks J, Reddy B, Planet P, Singh PK, Kaneko Y, Wolfgang MC, Hsiao YS, Tong L, Prince A (2006) Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin. Invest. 2297-2305. Stahl DA, Tiedje J (2002) Microbial ecology and genomics: A crossroads of opportunity. In: Critical Issues Colloquia of Am. Soc. Microbiol., Washington DC., USA. Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 99:15451-15455. Steenbergen JN, Casadevall A (2006) The evolution of human fungal pathogens. In: Evolution of Microbial Pathogens. (Seifert HS, DiRita VJ, eds.) 327-346. The ASM Press, Washington DC, USA. Swift S, Downie JA, Whitehead NA, Barnard AM, Salmond GP, Williams P (2001) Quorum sensing as a population-density-dependent determinant of bacterial physiology. Adv. Microb. Physiol. 45:199-270. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Internat. Immunol. 17:1-14. Tateda K, Standiford TJ, Pechere JC, Yamaguchi K (2004) Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors. Curr. Pharm. 10:3055-3065. Torsvik V, Øvreås L, Thingstad TF (2002) Prokaryotic diversity — magnitude, dynamics, and controlling factors. Science 296:1064-1066. Virk A, Steckelberg JM (2000) Clinical aspects of antimicrobial resisistance. Mayo Clin. Proc. 75:200-214. Wilson M (2008) Bacteriology of Humans — An Ecological Perspective. Blackwell Publ. Ltd., Oxford, UK. Wang X, Heazlewood SP, Krause DO, Florin TH (2003) Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J. Appl. Microbiol. 95:508-520. Wexler H (2007) Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20:593-621. Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel M, Lory S, Greenberg EP (2001) Gene expression in Pseudomonas aeruginosa biofilms. Nature 413(6858):860- 864. Whitman WB, Coleman DC, Wiebe WJ (1998) Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. USA 95:6578-6583. 50 Åêîëîã³÷íà áåçïåêà òà ïðèðîäîêîðèñòóâàííÿ Woese CR, Kandler O, Wheelis ML (1990) Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc. Natl. Acad. Sci. USA 87:4576-4579. Wolfe AJ (2005) The acetate switch. Microbiol. Mol. Biol. Rev. 69:12-50. Wright EM, Hirayama BA, Loo DF (2007) Active sugar transport in health and disease. J. Intern. Med. 261:32-43. Xu J, Gordon JI (2003) Honor thy symbionts. Proc. Natl. Acad. Sci. USA 100:10452-10459. Yachi S, Loreau M (1999) Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. Proc. Natl. Acad. Sci. USA 96:1463-1468. Yamanaka T, Helgeland L, Farstad IN, Fukushima H, Midtvedt T, Brandtzaeg P (2003) Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer’s patches. J. Immunol. 170:816-822. Zengler K, Toledo G, Rappe M, Elkins J, Mathur EJ, Short JM, Keller M (2002) Cultivating the uncultured. Proc. Natl. Acad. Sci. USA 99:15681-15686. Zhao J, Yu H, Luo J-H, Cao Z-W, Li Y-X (2006) Hierarchical modularity of nested bow-ties in metabolic networks. BMC Bioinformatics 7:386. doi:10.1186/1471-2105- 7-386. Zuckerkandl E, Pauling L (1965) Molecules as documents of evolutionary history. J. Theor. Biol. 8:357-366. ___________________________ Authors address: Prof. Dr. sc. med. Gerhard Gerber Fibona Health Products GmbH Heinrich-Hertz-Straße 2 65232 Taunusstein Germany E-Mail: g.gerber@f-h-p.eu Îòðèìàíî 15.06. 2008 ð.